Searches , social queries for ANIFROLUMAB

Search references for ANIFROLUMAB. Phrases containing ANIFROLUMAB

See searches and references containing ANIFROLUMAB!

Searches containing ANIFROLUMAB

ANIFROLUMAB

  • Anifrolumab

    • Monoclonal antibody

    Anifrolumab, sold under the brand name Saphnelo, is a monoclonal antibody used for the treatment of systemic lupus erythematosus. It binds to the type

    Anifrolumab

    Anifrolumab

  • Rosuvastatin

    • Statin medication

    v t e AstraZeneca Products Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide

    Rosuvastatin

    Rosuvastatin

    Rosuvastatin

  • Omeprazole

    • Medication to treat gastroesophageal reflux disease and other conditions

    v t e AstraZeneca Products Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide

    Omeprazole

    Omeprazole

  • Propofol

    • Intravenous medication used in anesthesia

    v t e AstraZeneca Products Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide

    Propofol

    Propofol

    Propofol

  • MedImmune

    • Biopharmaceutical company, acquired by AstraZeneca in 2007

    pasudotox (anti-CD22) benralizumab (anti-IL-5R) tralokinumab (anti-IL-13) anifrolumab (anti-IFN-aR) nirsevimab (anti-RSV) MedImmune, Inc. v. Genentech, Inc

    MedImmune

    MedImmune

  • Quetiapine

    • Atypical antipsychotic medication

    v t e AstraZeneca Products Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide

    Quetiapine

    Quetiapine

    Quetiapine

  • Salbutamol/budesonide

    • Medication

    v t e AstraZeneca Products Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide

    Salbutamol/budesonide

    Salbutamol/budesonide

  • Tofacitinib

    • Medication

    (IFN-ω, IFNW1) Peginterferon alfa-2a Peginterferon alfa-2b Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept

    Tofacitinib

    Tofacitinib

    Tofacitinib

  • Scleroderma

    • Group of autoimmune diseases resulting in abnormal growth of connective tissue

    haematopoietic stem cell transplantation, CD19 CAR-T, bispecific antibodies, anifrolumab (via IFN-I), belimumab (anti-BAFF), MT-7117 (melanocortin), FcRn inhibitors

    Scleroderma

    Scleroderma

    Scleroderma

  • Pascal Soriot

    • French businessman

    v t e AstraZeneca Products Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide

    Pascal Soriot

    Pascal Soriot

    Pascal_Soriot

  • Esomeprazole

    • Medication which reduces stomach acid

    v t e AstraZeneca Products Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide

    Esomeprazole

    Esomeprazole

    Esomeprazole

  • Cucurbitacin

    • Class of biochemical compounds

    (IFN-ω, IFNW1) Peginterferon alfa-2a Peginterferon alfa-2b Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept

    Cucurbitacin

    Cucurbitacin

    Cucurbitacin

  • Sodium zirconium cyclosilicate

    • Medication used to treat high blood potassium

    v t e AstraZeneca Products Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide

    Sodium zirconium cyclosilicate

    Sodium zirconium cyclosilicate

    Sodium_zirconium_cyclosilicate

  • Dapagliflozin

    • Diabetes medication

    v t e AstraZeneca Products Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide

    Dapagliflozin

    Dapagliflozin

    Dapagliflozin

  • Nirsevimab

    • Monoclonal antibody used as vaccine against RSV

    v t e AstraZeneca Products Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide

    Nirsevimab

    Nirsevimab

  • Sunitinib

    • Cancer medication

    (IFN-ω, IFNW1) Peginterferon alfa-2a Peginterferon alfa-2b Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept

    Sunitinib

    Sunitinib

    Sunitinib

  • Spartalizumab

    • Monoclonal antibody

    system Immune system Human Immunosuppression: Abrilumab Adalimumab# Anifrolumab Atorolimumab Avelumab Avdoralimab Belimumab Bleselumab Brodalumab Camidanlumab

    Spartalizumab

    Spartalizumab

  • Eculizumab

    • Pharmaceutical drug

    v t e AstraZeneca Products Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide

    Eculizumab

    Eculizumab

  • Zolmitriptan

    • Medication used in treatment of migraines

    v t e AstraZeneca Products Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide

    Zolmitriptan

    Zolmitriptan

    Zolmitriptan

  • Budesonide/formoterol

    • Medication for asthma & chronic obstructive pulmonary disease

    v t e AstraZeneca Products Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide

    Budesonide/formoterol

    Budesonide/formoterol

    Budesonide/formoterol

  • Andexanet alfa

    • Medication

    v t e AstraZeneca Products Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide

    Andexanet alfa

    Andexanet_alfa

  • Candesartan

    • Angiotensin II receptor antagonist

    v t e AstraZeneca Products Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide

    Candesartan

    Candesartan

    Candesartan

  • Ruxolitinib

    • Medication

    (IFN-ω, IFNW1) Peginterferon alfa-2a Peginterferon alfa-2b Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept

    Ruxolitinib

    Ruxolitinib

    Ruxolitinib

  • TRAF5

    • Protein-coding gene in the species Homo sapiens

    (IFN-ω, IFNW1) Peginterferon alfa-2a Peginterferon alfa-2b Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept

    TRAF5

    TRAF5

    TRAF5

  • Zeneca

    • British multinational pharmaceutical company

    v t e AstraZeneca Products Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide

    Zeneca

    Zeneca

  • Budesonide

    • Type of corticosteroid medication

    v t e AstraZeneca Products Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide

    Budesonide

    Budesonide

    Budesonide

  • Metoprolol

    • Beta blocker medication

    v t e AstraZeneca Products Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide

    Metoprolol

    Metoprolol

    Metoprolol

  • Sifalimumab

    • Human monoclonal antibody

    had been terminated in favor of moving a competing internal product, anifrolumab, into Phase III trials. Greth W, Robbie GJ, Brohawn P, Hultquist M, Yao

    Sifalimumab

    Sifalimumab

    Sifalimumab

  • Cytokine

    • Category of small signaling proteins

    (IFN-ω, IFNW1) Peginterferon alfa-2a Peginterferon alfa-2b Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept

    Cytokine

    Cytokine

    Cytokine

  • TNF inhibitor

    • Class of immunosuppressive drug

    (IFN-ω, IFNW1) Peginterferon alfa-2a Peginterferon alfa-2b Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept

    TNF inhibitor

    TNF inhibitor

    TNF_inhibitor

  • Etanercept

    • Biopharmaceutical for autoimmune diseases

    (IFN-ω, IFNW1) Peginterferon alfa-2a Peginterferon alfa-2b Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept

    Etanercept

    Etanercept

  • Ticagrelor

    • Coronary medication

    v t e AstraZeneca Products Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide

    Ticagrelor

    Ticagrelor

    Ticagrelor

  • Baricitinib

    • Chemical compound

    (IFN-ω, IFNW1) Peginterferon alfa-2a Peginterferon alfa-2b Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept

    Baricitinib

    Baricitinib

    Baricitinib

  • Erythropoietin receptor

    • Protein-coding gene in the species Homo sapiens

    (IFN-ω, IFNW1) Peginterferon alfa-2a Peginterferon alfa-2b Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept

    Erythropoietin receptor

    Erythropoietin receptor

    Erythropoietin_receptor

  • Atenolol

    • Beta blocker medication

    v t e AstraZeneca Products Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide

    Atenolol

    Atenolol

    Atenolol

  • Theralizumab

    • Monoclonal antibody

    system Immune system Human Immunosuppression: Abrilumab Adalimumab# Anifrolumab Atorolimumab Avelumab Avdoralimab Belimumab Bleselumab Brodalumab Camidanlumab

    Theralizumab

    Theralizumab

  • Thrombopoietin mimetics

    • Class of drugs

    (IFN-ω, IFNW1) Peginterferon alfa-2a Peginterferon alfa-2b Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept

    Thrombopoietin mimetics

    Thrombopoietin_mimetics

  • Erythropoietin

    • Protein that stimulates red blood cell production

    (IFN-ω, IFNW1) Peginterferon alfa-2a Peginterferon alfa-2b Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept

    Erythropoietin

    Erythropoietin

    Erythropoietin

  • Denosumab

    • Human monoclonal antibody

    (IFN-ω, IFNW1) Peginterferon alfa-2a Peginterferon alfa-2b Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept

    Denosumab

    Denosumab

  • Deuruxolitinib

    • Chemical compound

    (IFN-ω, IFNW1) Peginterferon alfa-2a Peginterferon alfa-2b Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept

    Deuruxolitinib

    Deuruxolitinib

    Deuruxolitinib

  • Janus kinase inhibitor

    • Immune modulating medication

    (IFN-ω, IFNW1) Peginterferon alfa-2a Peginterferon alfa-2b Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept

    Janus kinase inhibitor

    Janus_kinase_inhibitor

  • Alexion Pharmaceuticals

    • American healthcare company

    v t e AstraZeneca Products Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide

    Alexion Pharmaceuticals

    Alexion Pharmaceuticals

    Alexion_Pharmaceuticals

  • AstraZeneca

    • Swedish-British pharmaceutical company

    v t e AstraZeneca Products Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide

    AstraZeneca

    AstraZeneca

    AstraZeneca

  • Louis Schweitzer

    • French businessman (1942–2025)

    v t e AstraZeneca Products Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide

    Louis Schweitzer

    Louis Schweitzer

    Louis_Schweitzer

  • Interferon type I

    • Cytokine

    (IFN-ω, IFNW1) Peginterferon alfa-2a Peginterferon alfa-2b Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept

    Interferon type I

    Interferon type I

    Interferon_type_I

  • Ravulizumab

    • Pharmaceutical drug

    v t e AstraZeneca Products Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide

    Ravulizumab

    Ravulizumab

  • List of therapeutic monoclonal antibodies

    • the original on 5 February 2018. Retrieved 5 October 2020. "Saphnelo- anifrolumab injection, solution". DailyMed. Archived from the original on 12 August

    List of therapeutic monoclonal antibodies

    List of therapeutic monoclonal antibodies

    List_of_therapeutic_monoclonal_antibodies

  • Upadacitinib

    • Biopharmaceutical drug

    (IFN-ω, IFNW1) Peginterferon alfa-2a Peginterferon alfa-2b Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept

    Upadacitinib

    Upadacitinib

    Upadacitinib

  • Isosorbide mononitrate

    • Chemical compound

    v t e AstraZeneca Products Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide

    Isosorbide mononitrate

    Isosorbide mononitrate

    Isosorbide_mononitrate

  • Disufenton sodium

    • Chemical compound

    v t e AstraZeneca Products Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide

    Disufenton sodium

    Disufenton sodium

    Disufenton_sodium

  • Tom McKillop

    • Scottish chemist

    v t e AstraZeneca Products Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide

    Tom McKillop

    Tom_McKillop

  • Tixagevimab/cilgavimab

    • Monoclonal antibody treatment for COVID-19

    v t e AstraZeneca Products Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide

    Tixagevimab/cilgavimab

    Tixagevimab/cilgavimab

    Tixagevimab/cilgavimab

  • Acalabrutinib

    • Chemical compound

    v t e AstraZeneca Products Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide

    Acalabrutinib

    Acalabrutinib

    Acalabrutinib

  • Motavizumab

    • Monoclonal antibody

    v t e AstraZeneca Products Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide

    Motavizumab

    Motavizumab

  • Filgrastim

    • Medication

    (IFN-ω, IFNW1) Peginterferon alfa-2a Peginterferon alfa-2b Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept

    Filgrastim

    Filgrastim

    Filgrastim

  • Anastrozole

    • Chemical compound

    v t e AstraZeneca Products Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide

    Anastrozole

    Anastrozole

    Anastrozole

  • Oclacitinib

    • Medication

    (IFN-ω, IFNW1) Peginterferon alfa-2a Peginterferon alfa-2b Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept

    Oclacitinib

    Oclacitinib

    Oclacitinib

  • Roflumilast

    • Medication

    v t e AstraZeneca Products Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide

    Roflumilast

    Roflumilast

    Roflumilast

  • Trastuzumab deruxtecan

    • Medication

    v t e AstraZeneca Products Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide

    Trastuzumab deruxtecan

    Trastuzumab deruxtecan

    Trastuzumab_deruxtecan

  • Roxadustat

    • Anti-anemia medication

    v t e AstraZeneca Products Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide

    Roxadustat

    Roxadustat

    Roxadustat

  • Durvalumab

    • Pharmaceutical drug

    v t e AstraZeneca Products Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide

    Durvalumab

    Durvalumab

    Durvalumab

  • Palivizumab

    • Pharmaceutical drug

    v t e AstraZeneca Products Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide

    Palivizumab

    Palivizumab

  • Deucravacitinib

    • Chemical compound

    (IFN-ω, IFNW1) Peginterferon alfa-2a Peginterferon alfa-2b Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept

    Deucravacitinib

    Deucravacitinib

    Deucravacitinib

  • Bicalutamide

    • Antiandrogen medication

    v t e AstraZeneca Products Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide

    Bicalutamide

    Bicalutamide

    Bicalutamide

  • Astra AB

    • Swedish multinational pharmaceutical company

    v t e AstraZeneca Products Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide

    Astra AB

    Astra AB

    Astra_AB

  • Asfotase alfa

    • Pharmaceutical drug

    v t e AstraZeneca Products Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide

    Asfotase alfa

    Asfotase_alfa

  • Oxford–AstraZeneca COVID-19 vaccine

    • Viral vector vaccine for prevention of COVID-19

    v t e AstraZeneca Products Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide

    Oxford–AstraZeneca COVID-19 vaccine

    Oxford–AstraZeneca COVID-19 vaccine

    Oxford–AstraZeneca_COVID-19_vaccine

  • Janus kinase

    • Family of intracellular tyrosine kinases

    (IFN-ω, IFNW1) Peginterferon alfa-2a Peginterferon alfa-2b Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept

    Janus kinase

    Janus_kinase

  • JAK-STAT signaling pathway

    • Biological signaling pathway h

    (IFN-ω, IFNW1) Peginterferon alfa-2a Peginterferon alfa-2b Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept

    JAK-STAT signaling pathway

    JAK-STAT_signaling_pathway

  • Interferon

    • Signaling proteins released by host cells in response to the presence of pathogens

    (IFN-ω, IFNW1) Peginterferon alfa-2a Peginterferon alfa-2b Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept

    Interferon

    Interferon

    Interferon

  • CD40 ligand

    • Protein found in humans

    (IFN-ω, IFNW1) Peginterferon alfa-2a Peginterferon alfa-2b Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept

    CD40 ligand

    CD40 ligand

    CD40_ligand

  • Myokine

    • Class of proteins produced by muscle

    (IFN-ω, IFNW1) Peginterferon alfa-2a Peginterferon alfa-2b Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept

    Myokine

    Myokine

  • Interferon gamma

    • InterPro Family

    (IFN-ω, IFNW1) Peginterferon alfa-2a Peginterferon alfa-2b Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept

    Interferon gamma

    Interferon gamma

    Interferon_gamma

  • Exenatide

    • Medication

    v t e AstraZeneca Products Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide

    Exenatide

    Exenatide

    Exenatide

  • Granulocyte-macrophage colony-stimulating factor

    • Mammalian protein found in Homo sapiens

    (IFN-ω, IFNW1) Peginterferon alfa-2a Peginterferon alfa-2b Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept

    Granulocyte-macrophage colony-stimulating factor

    Granulocyte-macrophage colony-stimulating factor

    Granulocyte-macrophage_colony-stimulating_factor

  • Tamoxifen

    • Selective estrogen receptor modulator

    v t e AstraZeneca Products Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide

    Tamoxifen

    Tamoxifen

    Tamoxifen

  • Ritlecitinib

    • Medication to treat hair loss

    (IFN-ω, IFNW1) Peginterferon alfa-2a Peginterferon alfa-2b Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept

    Ritlecitinib

    Ritlecitinib

    Ritlecitinib

  • Epoetin alfa

    • Pharmaceutical drug

    (IFN-ω, IFNW1) Peginterferon alfa-2a Peginterferon alfa-2b Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept

    Epoetin alfa

    Epoetin_alfa

  • IFNA2

    • Mammalian protein found in Homo sapiens

    (IFN-ω, IFNW1) Peginterferon alfa-2a Peginterferon alfa-2b Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept

    IFNA2

    IFNA2

    IFNA2

  • TNF receptor associated factor

    • (IFN-ω, IFNW1) Peginterferon alfa-2a Peginterferon alfa-2b Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept

    TNF receptor associated factor

    TNF_receptor_associated_factor

  • Janus kinase 2

    • Non-receptor tyrosine kinase and coding gene in humans

    (IFN-ω, IFNW1) Peginterferon alfa-2a Peginterferon alfa-2b Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept

    Janus kinase 2

    Janus kinase 2

    Janus_kinase_2

  • B-cell activating factor

    • Mammalian protein found in Homo sapiens

    (IFN-ω, IFNW1) Peginterferon alfa-2a Peginterferon alfa-2b Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept

    B-cell activating factor

    B-cell activating factor

    B-cell_activating_factor

  • Ectodysplasin A receptor

    • Protein-coding gene in the species Homo sapiens

    (IFN-ω, IFNW1) Peginterferon alfa-2a Peginterferon alfa-2b Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept

    Ectodysplasin A receptor

    Ectodysplasin A receptor

    Ectodysplasin_A_receptor

  • Goserelin

    • Chemical compound

    v t e AstraZeneca Products Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide

    Goserelin

    Goserelin

    Goserelin

  • Pegfilgrastim

    • Monoclonal antibody

    (IFN-ω, IFNW1) Peginterferon alfa-2a Peginterferon alfa-2b Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept

    Pegfilgrastim

    Pegfilgrastim

  • ATC code L04

    • Pharmaceutical drug classification

    L04AG08 Ocrelizumab L04AG09 Emapalumab L04AG10 Inebilizumab L04AG11 Anifrolumab L04AG12 Ofatumumab L04AG13 Teprotumumab L04AG14 Ublituximab L04AG15 Divozilimab

    ATC code L04

    ATC_code_L04

  • CD40

    • Mammalian protein found in humans

    (IFN-ω, IFNW1) Peginterferon alfa-2a Peginterferon alfa-2b Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept

    CD40

    CD40

    CD40

  • APRIL (protein)

    • Protein-coding gene in the species Homo sapiens

    (IFN-ω, IFNW1) Peginterferon alfa-2a Peginterferon alfa-2b Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept

    APRIL (protein)

    APRIL (protein)

    APRIL_(protein)

  • Sebelipase alfa

    • Pharmaceutical compound

    v t e AstraZeneca Products Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide

    Sebelipase alfa

    Sebelipase_alfa

  • Sorafenib

    • Cancer treatment medicine

    (IFN-ω, IFNW1) Peginterferon alfa-2a Peginterferon alfa-2b Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept

    Sorafenib

    Sorafenib

    Sorafenib

  • Eltrombopag

    • Chemical compound

    (IFN-ω, IFNW1) Peginterferon alfa-2a Peginterferon alfa-2b Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept

    Eltrombopag

    Eltrombopag

    Eltrombopag

  • Brompheniramine

    • Chemical compound

    v t e AstraZeneca Products Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide

    Brompheniramine

    Brompheniramine

    Brompheniramine

  • Fas receptor

    • Protein found in humans

    (IFN-ω, IFNW1) Peginterferon alfa-2a Peginterferon alfa-2b Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept

    Fas receptor

    Fas receptor

    Fas_receptor

  • Olaparib

    • Chemical compound (cancer therapy drug)

    v t e AstraZeneca Products Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide

    Olaparib

    Olaparib

    Olaparib

  • Budesonide/glycopyrronium bromide/formoterol

    • Combination drug

    v t e AstraZeneca Products Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide

    Budesonide/glycopyrronium bromide/formoterol

    Budesonide/glycopyrronium_bromide/formoterol

  • Osimertinib

    • Chemical compound, used as a medication to treat lung cancer

    v t e AstraZeneca Products Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide

    Osimertinib

    Osimertinib

    Osimertinib

  • Momelotinib

    • Medication

    (IFN-ω, IFNW1) Peginterferon alfa-2a Peginterferon alfa-2b Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept

    Momelotinib

    Momelotinib

    Momelotinib

  • Granulocyte colony-stimulating factor

    • Mammalian protein found in humans

    (IFN-ω, IFNW1) Peginterferon alfa-2a Peginterferon alfa-2b Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept

    Granulocyte colony-stimulating factor

    Granulocyte colony-stimulating factor

    Granulocyte_colony-stimulating_factor

  • Interferon alfa

    • Pharmaceutical drug

    (IFN-ω, IFNW1) Peginterferon alfa-2a Peginterferon alfa-2b Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept

    Interferon alfa

    Interferon_alfa

  • Adipokine

    • Type of cytokines secreted by adipose tissue

    (IFN-ω, IFNW1) Peginterferon alfa-2a Peginterferon alfa-2b Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept

    Adipokine

    Adipokine

Affordable travel, tourism, home and auto insurance, legal services

travel, tourism, insurance

Searches for online references containing ANIFROLUMAB

ANIFROLUMAB

Search references containing ANIFROLUMAB

ANIFROLUMAB

Search queries for Facebook and twitter posts, hashtags with ANIFROLUMAB

ANIFROLUMAB

Follow users with usernames @ANIFROLUMAB or posting hashtags containing #ANIFROLUMAB

ANIFROLUMAB

Online names & meanings

Search queries for Facebook and twitter users, user names, hashtags with ANIFROLUMAB

ANIFROLUMAB

Top search, Social media, medium, facebook & news articles containing ANIFROLUMAB

ANIFROLUMAB

Searches for Acronyms & meanings containing ANIFROLUMAB

ANIFROLUMAB

Searches, Indeed job searches and job offers containing ANIFROLUMAB

Other words and meanings similar to

ANIFROLUMAB

Search in online dictionary sources & meanings containing ANIFROLUMAB

ANIFROLUMAB

Affordable travel, tourism, home and auto insurance, legal services

travel, tourism, insurance